$SRRK
Scholar Rock Holding Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$46.55
▲+0.84%+$0.390
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateScholar Rock Holding Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SRRK up today? It is at $46.55 (+0.84%), and our scanner flagged it 149 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SRRK spikes, and full due diligence on SRRK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SRRK 149 times in the last 30 days. Create a free account to track $SRRK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SRRK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRRK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystRegulation FD Disclosure, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Oct 1, 2026 · 3 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,362,050 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $200.0M in size · Priced at $45.85/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Woods Keith Officer | Sold (automatic/other) | -48K 0.04% of company | sold 7.7% | 572K | n/a | Sep 24, 26 |
Hallal David Officer | Sold (automatic/other) | -37K 0.03% of company | sold 2.2% | 1.60M | n/a | Sep 21, 26 |
Peng Katie Director | Sold (automatic/other) | -5K | sold 14% | 34K | $292K at $53.56 | Jul 1, 26 |
Reed Joshua Director | Sold (automatic/other) | -3K | sold 14% | 20K | $163K at $53.50 | Jul 1, 26 |
Burow Kristina Director | Sold (automatic/other) | -3K | sold 2.6% | 115K | $163K at $53.49 | Jul 1, 26 |
Flier Jeffrey S. Director | Sold (automatic/other) | -3K | sold 9.9% | 28K | $163K at $53.53 | Jul 1, 26 |
Gilman Michael Director | Sold (automatic/other) | -3K | sold 4.1% | 60K | $136K at $53.54 | Jul 1, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +7K | added 32% | 28K | n/a | Jun 4, 26 |
Peng Katie Director | Acquired (grant/award) | +7K | added 21% | 40K | n/a | Jun 4, 26 |
Gilman Michael Director | Acquired (grant/award) | +7K | added 12% | 62K | n/a | Jun 4, 26 |
Burow Kristina Director | Acquired (grant/award) | +7K | added 6.2% | 118K | n/a | Jun 4, 26 |
Brudnick Richard Director | Acquired (grant/award) | +7K | added 45% | 22K | n/a | Jun 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SRRK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRRK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SRRK last traded at $46.55, up 0.84% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Scholar Rock Holding Corporation Common Stock (SRRK) is next expected to report earnings on Friday, November 13, 2026, about 40 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SRRK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SRRK 149 times in the last 30 days.
SRRK (Scholar Rock Holding Corporation Common Stock) trades on XNAS, with a market cap of about $5.70B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SRRK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SRRK discussion
Sign in to ask a question or join the discussion.